Agents must see, 71 R & D investment ranking of local pharmaceutical enterprises
-
Last Update: 2015-07-01
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Medical observer Report July 1, 2015 According to relevant data, this paper summarizes the R & D expenses of 71 pharmaceutical enterprises (incomplete statistics) in 2014, with a total R & D investment of 7.698 billion yuan (data as of December 31, 2014) According to the top ten R & D investment, Fosun Pharmaceutical ranks first with 685 million yuan, followed by Hengrui pharmaceutical with 652 million yuan and Haizheng pharmaceutical with 558 million yuan The R & D expenses of Kelun pharmaceutical, jiankangyuan, Tianshili and humanwell are over 300 million yuan The following are the R & D expenses of 71 pharmaceutical companies for reference only.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
